Equity gaps in lung cancer molecular testing persist; reflex testing and nurse navigation speed care, while coverage and access barriers stall outcomes
Christopher A. D'Avella, MD
Advertisement
Christopher A. D’Avella is a thoracic medical oncologist at the University of Pennsylvania, where he serves as section chief of hematology/oncology at Penn Presbyterian Medical Center, codirector of Cancer Diagnostics Clinic, and assistant professor of clinical medicine.
Articles by Christopher A. D'Avella, MD
Reflex molecular testing and nurse navigation cut delays in lung cancer care, helping more patients get targeted results before first-line therapy, says Christopher D'Avella, MD.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
ATTR-CM Incidence, Prevalence Rose Sharply in the US
4
Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS
5